|
Sudarshan Pharma Industries Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
697.91 Cr.
|
P/BV
|
6.25
|
Book Value (Rs.)
|
4.64
|
|
52 Week High/Low (Rs.)
|
54/9
|
FV/ML
|
1/4000
|
P/E(X)
|
43.75
|
|
Bookclosure
|
23/11/2024
|
EPS (Rs.)
|
0.66
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 21.63 | 15.23 | 9.50 | 7.19 | 3.57 |
| | | | | | |
| Net CashFlow From Operating Activities | 35.22 | 6.01 | -28.79 | -3.74 | 2.77 |
| Net Cash Used In Investing Activities | -20.41 | -5.49 | -25.65 | -1.49 | -1.29 |
| Net Cash Used From Financing Activities | -14.45 | -12.10 | 65.93 | 4.21 | -1.49 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.41 | -11.57 | 11.48 | -1.02 | -0.01 |
| Cash And Cash Equivalents Begin of Year | 0.14 | 11.72 | 0.24 | 1.25 | 1.27 |
| Cash And Cash Equivalents End Of Year | 0.55 | 0.14 | 11.72 | 0.24 | 1.25 |
